Biotricity (NASDAQ:BTCY) Downgraded to “Neutral” at HC Wainwright

HC Wainwright cut shares of Biotricity (NASDAQ:BTCYFree Report) from a buy rating to a neutral rating in a research note released on Monday, Marketbeat reports.

Biotricity Price Performance

Shares of BTCY opened at $0.95 on Monday. The stock has a market capitalization of $8.14 million, a price-to-earnings ratio of -0.60 and a beta of 2.34. Biotricity has a 12-month low of $0.70 and a 12-month high of $7.56. The company’s fifty day moving average is $1.72.

Biotricity Company Profile

(Get Free Report)

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.

Recommended Stories

Receive News & Ratings for Biotricity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotricity and related companies with's FREE daily email newsletter.